GlassScriptPhysician profile
Stasia Eileen Richter
NPI 1508869744
$3,413.27
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $660 · 2021: $1,132 · 2022: $867 · 2023: $507 · 2024: $20.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $527.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $691.73 | 2020-2023 | |
| Novo Nordisk INC | $572.50 | 2019-2023 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $406.84 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $193.23 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $188.40 | 2019-2023 | |
| Amgen INC. | $171.36 | 2019-2023 | Evenity, Prolia |
| Takeda Pharmaceuticals U.S.A., INC. | $163.36 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $148.69 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $132.93 | 2021-2023 | Xifaxan, Trulance |
| Eisai INC. | $97.55 | 2021-2022 | |
| Sanofi Pasteur INC. | $94.31 | 2020-2023 | |
| Ironwood Pharmaceuticals, INC | $71.34 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $58.04 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $57.24 | 2022 | |
| Lilly USA, LLC | $49.51 | 2020-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $43.71 | 2020-2023 | Shingrix |
| Exact Sciences Corporation | $41.54 | 2023 | Cologuard Collection Kit |
| Dexcom, INC. | $40.02 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.94 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $28.81 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $26.79 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.17 | 2024 | Lifevest |
| Ibsa Pharma INC. | $18.41 | 2021 | |
| Janssen Pharmaceuticals, INC | $18.40 | 2019 | |
| Hologic Sales and Service, LLC | $16.72 | 2022 | |
| Genentech USA, INC. | $16.45 | 2020 | |
| Astellas Pharma US INC | $12.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stasia Richter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.